Table 2.
Visits to any health care provider in the post-diagnosis period, by participant group
Patient group | TB/HIV |
TB-only |
HIV-only |
||||||
---|---|---|---|---|---|---|---|---|---|
(n = 116) |
(n = 40) |
(n = 298) |
|||||||
Visit type | TB/HIV visits | TB visits | HIV visits | TB/HIV visits | TB visits | HIV visits | TB/HIV visits | TB visits | HIV visits |
Study clinic visits, mean (SD) | 5.0 (4.6) | 10.9 (14.2) | 2.2 (4.6) | 0.8 (.6) | 14.5 (14.6) | 0.1 (.2) | 0 | 0 | 4.4 (2.0) |
Visits toaother providers, mean (SD) | 0.3 (0.7) | 0.2 (0.7) | 0.6 (2.6) | 0.1 (0.2) | 0 | 0.2 (0.7) | |||
Subtotal, all providers, mean | 5.0 | 11.2 | 2.2 | 0.8 | 15.1 | 0.1 | 0 | 0 | 4.6 |
Total visits, all visit types, all providers | 18.4 | 16.0 | 5.1 |
Note: SD, standard deviation.
Other public clinic, pharmacy, general practitioner, hospital-outpatient, hospital-inpatient and traditional healers.